Clinical Trial Detail

NCT ID NCT02584829
Title Localized Radiation Therapy or Recombinant Interferon Beta and MSB0010718C With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Fred Hutchinson Cancer Research Center
Indications

Merkel cell carcinoma

Therapies

IFN-B

Avelumab

Age Groups: adult

No variant requirements are available.